Intellectual property medicaid spend down starts with the same resource filter as cash and brokerage accounts. Patents, copyrights, trademarks you can assign, and royalty rights you can sell count as countable resources at fair market value in most aged, blind, disabled, and long-term-care Medicaid programs. Monthly royalty checks from a license usually count as unearned income in the month received, not as a lump asset you eliminate once. Selling the patent or copyright for documented fair market value converts IP into spend-down proceeds. Licensing while you keep ownership often leaves the underlying IP on the worksheet even when checks help with bills.
Medicaid workers do not treat intellectual property as invisible because it lacks a stock ticker. If you can assign, license for a lump sum, or sell the underlying rights, the manual usually lists the interest as a resource.
Federal SSI resource policy and state Medicaid manuals group patents, copyrights, trademarks, and mineral royalties with other property rights that produce income or have market value. Mississippi and North Carolina resource chapters both treat royalty-producing property as countable unless a narrow exclusion applies.
Talia in Seattle never incorporated a company. She filed the patent in her name and collected checks through a d/b/a account. Apple Health eligibility staff still asked for the USPTO assignment history, the license agreement, and two years of royalty statements before COPES approval.
Morris in Austin held his patent through Morris R. Chen Consulting LLC for tax reasons. Texas HHSC looked through the LLC to Morris as sole member and counted the patent bundle the same way it counted his personal Schwab IRA.
Start with the Medicaid countable assets list and the Medicaid asset limits guide so you know the cap after you label the patent line.
Common mistake:Assuming Medicaid only counts "money in the bank." A patent with zero current royalties can still carry six-figure fair market value on an appraiser's worksheet.
Caseworkers rarely accept your hope that the invention will "take off next year." They want fair market value evidence: prior sales of similar patents, license terms, discounted cash flow from royalties, or a written valuation from a patent broker or CPA.
Pending patent applications count when you can sell or assign the application under USPTO rules. Issued patents count at the value of the assignable rights, including exclusive licenses you could terminate for a sale.
Talia's 2025 broker letter estimated $96,000 for her bed-sensor patent based on her existing license fee, comparable med-device assignments, and remaining patent term through 2038. King County HCA accepted the memo after the licensee confirmed it would not block assignment to a third party for a separate fee.
Morris submitted a $118,000 valuation for his downhole tool patent from an oilfield equipment broker. HHSC used that figure even though 2025 royalty checks totaled only $34,200. Low current income did not shrink the resource line.
If the IP sits inside a small company, read small business Medicaid spend down for how entity ownership stacks with personal patents assigned to the business.
| Document | Why it matters | Typical source |
|---|---|---|
| USPTO assignment record | Shows who owns enforceable rights | USPTO Patent Assignment Search |
| Executed license agreement | Proves income stream and transfer limits | Applicant or licensee copy |
| Royalty statements (24 months) | Supports income vs lump value | Licensee accounting |
| Written patent broker valuation | Fair market value for sale planning | Independent broker or CPA |
| Prior arm's-length sale offers | Third-party price anchor | Letter of intent, email trail |
| Tax return royalty line | Cross-check deposits you reported | Schedule E or C |
Royalty checks blur two Medicaid tests. The patent or copyright itself is a resource. The check you deposit this month is usually income.
SSA Program Operations Manual System sections on unearned income treat royalties like rent or patent license fees when they arrive periodically. Medicaid aged and disabled programs often follow the same split in state manuals.
Morris in Austin received $2,850 on the 15th of each month from three non-exclusive field licenses on his downhole tool patent. Travis County HHSC counted each deposit as March income when it hit his Frost Bank account. The patent itself still showed $118,000 on the resource side of his STAR+PLUS worksheet.
When Morris left $6,400 of February and March royalties in checking on April 1, 2026, that balance counted as a resource on the snapshot, on top of income already counted in prior months.
Heavy royalty months can also push income above community Medicaid caps even when resources finally sit under $2,000. Read Medicaid spend down on monthly income when Social Security plus royalties fail the income test.
Sale and license solve different problems. Sale converts IP into cash you can route through allowed spend-down channels. License keeps the asset in your name while trading future checks for present cash flow.
A full assignment sale records at the USPTO, ends your ownership, and deposits proceeds in an account you control. That cash counts until you spend it on exempt items, verified debt, care costs, or other lawful channels described in paying debt during Medicaid spend down.
A license without assignment leaves you as owner. Medicaid still asks what a buyer would pay for the patent today. Talia considered a 10-year exclusive license with a $200,000 upfront fee. Her benefits counselor warned that a large upfront fee might count as income in the receipt month and still leave residual patent value if she kept reversion rights.
Talia chose a full assignment sale to the same manufacturer for $102,000 after her broker updated the valuation. She recorded the assignment, deposited the wire to BECU, paid $28,400 in private-pay adult family home invoices, funded irrevocable funeral prep within Washington limits, and retired $11,200 in medical collections before her May 1 snapshot showed $1,940 in checking.
Morris could not spend down the patent by signing another license. He needed either fair market sale or a documented strategy that reduced assignable value without a gift. He eventually sold the patent to an unrelated oilfield services firm for $115,000 with USPTO assignment proof and applied proceeds toward care and debt while his wife remained in their Austin home.
| Path | Resource worksheet | Income test | Spend-down effect |
|---|---|---|---|
| Full assignment sale at fair market value | Patent line drops after USPTO assignment | Lump proceeds may count as income month received in some programs; then leftover cash is a resource | Strong when proceeds fund allowed spends before snapshot |
| Ongoing royalty license, you keep patent | Patent usually stays at fair market value | Each royalty check counts when deposited | Does not remove the asset; helps cash flow only |
| Large upfront license fee, keep ownership | Patent often remains with reduced or disputed value | Upfront fee often treated as unearned income | Rarely replaces a full sale for resource cap cases |
| Gift or discount sale to family | May still show gifted value in look-back | N/A | Penalty risk; not a lawful spend-down shortcut |
Common mistake:Selling the patent to your son for $5,000 when the broker said $115,000. That discount is a look-back gift, similar to business transfers in transfer business Medicaid spend down.
Talia applied for Washington Apple Health COPES in King County after a fall limited her ability to live alone in her Capitol Hill condo. She owned the bed-sensor patent outright and held $6,800 in personal checking plus $4,100 in a royalty reserve account on February 1, 2026.
Her COPES worker requested the active license, USPTO maintenance fee receipts, and the broker valuation at $96,000. Combined countable resources far exceeded Washington's $2,000 individual standard for SSI-linked long-term-care programs in 2026.
Talia's manufacturer agreed to buy the patent outright for $102,000 in March 2026. She filed the assignment electronically, kept the confirmation number, and wired proceeds only to her personal BECU account, not her adult daughter's account.
She reported the sale on her change form within ten days, paid allowed bills, and ran the Washington Medicaid spend down calculator with $0 patent value post-assignment before May filing.
Washington HCA still reviewed the sale for look-back purposes because the buyer had licensed the patent since 2019. Talia's arm's-length price, third-party broker letter, and matching bank deposit satisfied the worker. A $10,000 family discount would have failed.
Morris entered Travis County STAR+PLUS planning with $118,000 patent value, $14,600 in checking, and monthly $2,850 royalty deposits. Licensing income covered utilities but did not solve the resource test.
He first asked HHSC whether three active licenses meant the patent was exempt as "self-support property." Texas staff denied the exclusion because Morris was not working full time in the field and planned to move to assisted living with waiver supports.
Morris tried to spend down by prepaying five years of license fees back to licensees. HHSC counted the prepaid amounts as retained value tied to the patent contract, not exempt personal property.
After counsel review, Morris sold the patent to an unrelated oilfield services company for $115,000, recorded the USPTO assignment, and paid $41,000 in verified debt, $22,000 in care invoices, and funeral prep within Texas limits before a June 1, 2026 snapshot near $1,880 in checking.
He modeled the path on the Texas Medicaid spend down calculator and compared royalty income months on monthly income spend-down rules when deposits continued through closing.
Patent transfers appear in public USPTO assignment records. Medicaid agencies do not need to guess whether you re-titled IP.
Gifting patent rights to a child for $0, or licensing exclusively to a family company for nominal fees, triggers the same uncompensated transfer analysis as cash gifts in 42 U.S.C. § 1396p. Read transferring assets to family and Medicaid and Medicaid gift penalty calculation before you move rights inside the 60-month window.
Bank data matches royalty deposits even when you omit Schedule E. See can Medicaid see bank accounts when Morris considered routing checks to a grandson's account.
Copyright catalogs and trademark portfolios follow the same sale-vs-license fork. Talia's path differs only in assignment office paperwork, not Medicaid math.
Pair IP sales with non-countable assets for Medicaid so you do not spend proceeds on items that still count.
Patent counting rules share a federal backbone through SSI-linked Medicaid manuals, but dollar caps differ. Washington Apple Health and Texas HHSC applied the $2,000 individual resource standard to Talia and Morris in 2026 before their sales closed.
California Medi-Cal's $130,000 individual cap changes how long a San Jose inventor might keep a licensed patent on paper, but licensing still does not erase fair market value. New York's $33,038 Chronic Care ceiling helps a Rochester songwriter with moderate catalog value but not a six-figure patent bundle.
Ohio Job and Family Services and Florida AHCA request royalty statements on many nursing-home applications when Schedule E royalties appear on tax returns. The sale-vs-license logic travels even when caps match Texas.
Income standards also vary. Washington and Texas may treat large upfront license fees differently from monthly royalties when COPES or STAR+PLUS income tests apply. Confirm both resource and income rules with the program you file, not a national blog summary.
Common mistake:Using California's $130,000 cap to plan Talia's Washington COPES case. King County follows Washington limits even when the licensee is a California company.
Enter patent fair market value in the same session as checking, IRAs, and vehicles. The calculator hub links state tools with 2026 resource caps.
Start with the Washington and Texas calculators when your facts look like Talia or Morris. Add California and Ohio if licensors or buyers sit in other states.
Return to the asset limits guide for homestead and CSRA rules after you zero out post-sale patent lines.
Yes in most aged, blind, disabled, and long-term-care Medicaid programs that use a resource test. Caseworkers value assignable patent rights at fair market value using broker letters, license terms, and USPTO records. Pending applications can count when you may sell or assign them.
Both tests can apply. The patent itself is usually a countable resource while you own it. Periodic royalty deposits typically count as unearned income in the month received. Money left in checking after the month ends can count again as a resource on the snapshot date.
Usually no for the resource cap. Licensing keeps ownership on the worksheet at fair market value while royalties flow as income. A full assignment sale for fair market value, with USPTO recording and proceeds in your name, is the standard way to remove patent value from the resource side.
Use a documented fair market value, sell to an unrelated buyer or have your child pay full price with appraisal proof, record the USPTO assignment, deposit proceeds to your account, and spend on allowed channels before your target snapshot. Below-market family sales inside the 60-month look-back can add penalty months.
No when you are the sole member or control the entity. Texas and Washington workers request operating agreements and still attribute patent value to you. Read small business Medicaid spend down rules when IP sits inside a company.
Bring USPTO assignment printouts, maintenance fee receipts, license agreements, 24 months of royalty statements, tax returns showing royalty lines, bank statements, broker or CPA valuations, and sale contracts with wire confirmations if you already sold.
State manuals often group copyrights, trademarks, and patents as income-producing property. The same sale-vs-license split applies. A music catalog you keep licensing usually stays countable at fair market value until you assign rights for fair compensation.
